GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Medfield Diagnostics AB (XSAT:MEDF) » Definitions » Debt-to-Asset

Medfield Diagnostics AB (XSAT:MEDF) Debt-to-Asset : 0.00 (As of Mar. 2024)


View and export this data going back to 2012. Start your Free Trial

What is Medfield Diagnostics AB Debt-to-Asset?

Medfield Diagnostics AB's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was kr0.00 Mil. Medfield Diagnostics AB's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was kr0.00 Mil. Medfield Diagnostics AB's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Mar. 2024 was kr72.20 Mil. Medfield Diagnostics AB's debt to asset for the quarter that ended in Mar. 2024 was 0.00.


Medfield Diagnostics AB Debt-to-Asset Historical Data

The historical data trend for Medfield Diagnostics AB's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medfield Diagnostics AB Debt-to-Asset Chart

Medfield Diagnostics AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Debt-to-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Medfield Diagnostics AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Debt-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Medfield Diagnostics AB's Debt-to-Asset

For the Medical Devices subindustry, Medfield Diagnostics AB's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medfield Diagnostics AB's Debt-to-Asset Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Medfield Diagnostics AB's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where Medfield Diagnostics AB's Debt-to-Asset falls into.



Medfield Diagnostics AB Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

Medfield Diagnostics AB's Debt-to-Asset for the fiscal year that ended in Dec. 2023 is calculated as

Medfield Diagnostics AB's Debt-to-Asset for the quarter that ended in Mar. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Medfield Diagnostics AB  (XSAT:MEDF) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.


Medfield Diagnostics AB Debt-to-Asset Related Terms

Thank you for viewing the detailed overview of Medfield Diagnostics AB's Debt-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Medfield Diagnostics AB (XSAT:MEDF) Business Description

Traded in Other Exchanges
N/A
Address
Medicinaregatan 8B, Gothenburg, SWE, 413 90
Medfield Diagnostics AB develops, markets and sells diagnostic instrumentation based on microwave technology. The company researches the use of microwave technology in stroke diagnostics. Its products consist of Strokefinder and Impending Applications.

Medfield Diagnostics AB (XSAT:MEDF) Headlines

No Headlines